Bristol Myers Squibb is a global biopharmaceutical company operating across more than 100 countries with approximately 32,500 employees worldwide. Founded in 1887 as Clinton Pharmaceutical Company, the company has over 135 years of experience developing medicines and therapies.
The company's research and development spans oncology, hematology, immunology, cardiology, fibrosis, cell therapy, and immunotherapy. Bristol Myers Squibb combines the resources and scale of a major pharmaceutical manufacturer with an entrepreneurial approach to innovation, enabling rapid development and deployment of treatments across multiple therapeutic areas.
The Bristol Myers Squibb Foundation supports health equity initiatives and vulnerable populations globally, reflecting the company's broader commitment to addressing healthcare disparities. The organisation has a documented history of breakthrough innovations, particularly in cardiovascular therapies and cancer immunotherapy, with ongoing emphasis on cell therapy development and advancing access to healthcare.
